September 17, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Capricor Therapeutics, Inc. (“Capricor” or “the Company”) (NASDAQ: CAPR). Investors who purchased Capricor securities prior to October 9, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
September 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MediaAlpha, Inc. (“MediaAlpha” or “the Company”) (NYSE: MAX). Investors who purchased MediaAlpha securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether MediaAlpha has violated federal… read more
September 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Celanese Corporation (“Celanese” or “the Company”) (NYSE: CE). Investors who purchased Celanese securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Celanese has violated federal… read more
September 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Galiano Gold Inc. (“Galiano” or “the Company”) (NYSE: GAU). Investors who purchased Galiano securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Galiano has violated… read more
September 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating the MeridianLink, Inc. (“MeridianLink”) (NYSE: MLNK) acquisition by funds advised by affiliates of Centerbridge Partners, L.P. (“Centerbridge”), a global investment firm. Investors who purchased MeridianLink and continue to hold to the present are encouraged to obtain additional information… read more
September 15, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of America’s Car-Mart, Inc. (“Car-Mart” or “the Company”) (NASDAQ: CRMT). Investors who purchased Car-Mart securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Car-Mart has violated… read more
September 15, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lesaka Technologies, Inc. (“Lesaka” or “the Company”) (NASDAQ: LSAK). Investors who purchased Lesaka securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Lesaka has violated… read more
September 15, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Skillz Inc. (“Skillz” or “the Company”) (NYSE: SKLZ). Investors who purchased Skillz securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Skillz has violated federal… read more
September 12, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Generac Holdings Inc. (“Generac” or “the Company”) (NYSE: GNRC). Investors who purchased Generac securities prior to May 3, 2023, and continue to hold to the present, are encouraged to obtain additional… read more
September 12, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cybin Inc. (“Cybin” or “the Company”) (NYSE: CYBN). Investors who purchased Cybin securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Cybin has violated federal… read more
September 11, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Matrix Service Company (“Matrix” or “the Company”) (NASDAQ: MTRX). Investors who purchased Matrix securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Matrix has violated… read more
September 11, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Soleno Therapeutics, Inc. (“Soleno” or “the Company”) (NASDAQ: SLNO). Investors who purchased Soleno securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Soleno has violated… read more
September 11, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Coherent Corp. (“Coherent” or “the Company”) (NYSE: COHR). Investors who purchased Coherent securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Coherent has violated federal… read more
September 10, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Summit Therapeutics Inc. (“Summit” or “the Company”) (NASDAQ: SMMT). Investors who purchased Summit securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Summit has violated… read more
September 8, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT). Investors who purchased Applied Therapeutics securities prior to January 3, 2024, and continue to hold to the present, are encouraged to… read more
September 5, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Agios Pharmaceuticals, Inc. (“Agios” or “the Company”) (NASDAQ: AGIO). Investors who purchased Agios securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Agios has violated… read more
September 5, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Barnes & Noble Education, Inc. (“Barnes & Noble” or “the Company”) (NYSE: BNED). Investors who purchased Barnes & Noble securities are encouraged to obtain additional information and assist the investigation. The… read more
September 3, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MarineMax, Inc. (“MarineMax” or “the Company”) (NYSE: HZO). Investors who purchased MarineMax securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether MarineMax has violated federal… read more
September 2, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of EHang Holdings Limited (“EHang” or “the Company”) (NASDAQ: EH). Investors who purchased EHang securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether EHang has violated… read more
September 2, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Valneva SE (“Valneva” or “the Company”) (NASDAQ: VALN). Investors who purchased Valneva securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Valneva has violated federal… read more
August 29, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Insperity, Inc. (“Insperity” or “the Company”) (NYSE: NSP). Investors who purchased Insperity securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Insperity has violated federal… read more
August 26, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sarepta Therapeutics, Inc. (“Sarepta” or “the Company”) (NASDAQ: SRPT). Investors who purchased Sarepta securities prior to June 22, 2022, and continue to hold to the present, are encouraged to obtain additional… read more
August 26, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 3D Systems Corporation (“3D Systems” or “the Company”) (NYSE: DDD). Investors who purchased 3D Systems securities prior to August 13, 2024, and continue to hold to the present, are encouraged to… read more
August 26, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rocket Pharmaceuticals, Inc. (“Rocket” or “the Company”) (NASDAQ: RCKT). Investors who purchased Rocket securities prior to September 17, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
August 26, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PepGen Inc. (“PepGen” or “the Company”) (NASDAQ: PEPG). Investors who purchased PepGen securities prior to March 7, 2024, and continue to hold to the present, are encouraged to obtain additional information… read more
August 25, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sensus Healthcare, Inc. (“Sensus” or “the Company”) (NASDAQ: SRTS). Investors who purchased Sensus securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Sensus has violated… read more
August 22, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Innovative Solutions and Support, Inc. (“IS&S” or “the Company”) (NASDAQ: ISSC). Investors who purchased IS&S securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether IS&S… read more
August 22, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating the agreement between Dayforce Inc. (“Dayforce”) (NYSE: DAY) and Thoma Bravo. Investors who purchased Dayforce and continue to hold to the present are encouraged to obtain additional information and assist the investigation. Investigation Details The investigation concerns whether… read more
August 21, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tandem Diabetes Care, Inc. (“Tandem” or “the Company”) (NASDAQ: TNDM). Investors who purchased Tandem securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Tandem has… read more
August 18, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating claims on behalf of investors in Soho House & Co Inc. (“Soho House” or “the Company”) (NYSE: SHCO) for potential breaches of fiduciary duty on the part of its directors and management. Investors who purchased Soho House and… read more
